{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:48:45Z","timestamp":1776091725325,"version":"3.50.1"},"reference-count":88,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Skeletal muscle requires a large increase in its ATP production to meet the energy needs of exercise. Normally, most of this increase in ATP is supplied by the aerobic process of oxidative phosphorylation. The main defects in muscle metabolism that interfere with production of ATP are (1) disorders of glycogenolysis and glycolysis, which prevent both carbohydrate entering the tricarboxylic acid cycle and the production of lactic acid; (2) mitochondrial myopathies where the defect is usually within the electron transport chain, reducing the rate of oxidative phosphorylation; and (3) disorders of lipid metabolism. Gas exchange measurements derived from exhaled gas analysis during cardiopulmonary exercise testing can identify defects in muscle metabolism because V.o2 and V.co2 are abnormal at the level of the muscle. Cardiopulmonary exercise testing may thus suggest a likely diagnosis and guide additional investigation. Defects in glycogenolysis and glycolysis are identified by a low peak V.o2 and absence of excess V.co2 from buffering of lactic acid by bicarbonate. Defects in the electron transport chain also result in low peak V.o2, but because there is an overreliance on anaerobic processes, lactic acid accumulation and excess carbon dioxide from buffering occur early during exercise. Defects in lipid metabolism result in only minor abnormalities during cardiopulmonary exercise testing. In defects of glycogenolysis and glycolysis and in mitochondrial myopathies, other features may include an exaggerated cardiovascular response to exercise, a low oxygen-pulse, and excessive ammonia release.<\/jats:p>","DOI":"10.1513\/annalsats.201701-014fr","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T10:39:05Z","timestamp":1496831945000},"page":"S129-S139","source":"Crossref","is-referenced-by-count":34,"title":["Cardiopulmonary Exercise Testing and Metabolic Myopathies"],"prefix":"10.1093","volume":"14","author":[{"given":"Marshall S.","family":"Riley","sequence":"first","affiliation":[{"name":"Queen\u2019s University, Belfast, Northern Ireland, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Paul","family":"Nicholls","sequence":"additional","affiliation":[{"name":"Queen\u2019s University, Belfast, Northern Ireland, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Cooper","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"2026020403045354200_bib1","volume-title":"Textbook of work physiology","author":"\u00c5strand","year":"1986","edition":"3rd ed"},{"key":"2026020403045354200_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ncl.2014.05.001","article-title":"Metabolic and mitochondrial myopathies","volume":"32","author":"Sharp","year":"2014","journal-title":"Neurol Clin"},{"key":"2026020403045354200_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-0035-1558973","article-title":"Metabolic myopathies","volume":"35","author":"Adler","year":"2015","journal-title":"Semin Neurol"},{"key":"2026020403045354200_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pmr.2011.11.011","article-title":"Exercise testing in metabolic myopathies","volume":"23","author":"Tarnopolsky","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2026020403045354200_bib5","volume-title":"Principles of exercise testing and interpretation","author":"Wasserman","year":"2012","edition":"5th ed"},{"key":"2026020403045354200_bib6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1152\/jappl.1983.55.5.1558","article-title":"Optimizing the exercise protocol for cardiopulmonary assessment","volume":"55","author":"Buchfuhrer","year":"1983","journal-title":"J Appl Physiol"},{"key":"2026020403045354200_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00421-009-1183-6","article-title":"Exponential protocols for cardiopulmonary exercise testing on treadmill and cycle ergometer","volume":"108","author":"Jamison","year":"2010","journal-title":"Eur J Appl Physiol"},{"key":"2026020403045354200_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1249\/01.MSS.0000084593.56786.DA","article-title":"A treadmill ramp protocol using simultaneous changes in speed and grade","volume":"35","author":"P\u00f3rsz\u00e1sz","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"2026020403045354200_bib9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.56.12.1733","article-title":"A non-ischemic forearm exercise test for the screening of patients with exercise intolerance","volume":"56","author":"Hogrel","year":"2001","journal-title":"Neurology"},{"key":"2026020403045354200_bib10","first-page":"19","article-title":"Turning down lipid oxidation during heavy exercise--what is the mechanism?","volume":"59","author":"Sahlin","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"2026020403045354200_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00599695","article-title":"Muscle substrate utilization from alveolar gas exchange in trained cyclists","volume":"72","author":"Riley","year":"1996","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"2026020403045354200_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10545-014-9771-y","article-title":"Exercise in muscle glycogen storage diseases","volume":"38","author":"Preisler","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"2026020403045354200_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1152\/jappl.1991.70.1.391","article-title":"Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency","volume":"70","author":"Lewis","year":"1991","journal-title":"J Appl Physiol (1985)"},{"key":"2026020403045354200_bib14","first-page":"13","article-title":"Myopathy due to a defect in muscle glycogen breakdown","volume":"10","author":"McArdle","year":"1951","journal-title":"Clin Sci"},{"key":"2026020403045354200_bib15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/hmg\/2.8.1291","article-title":"McArdle\u2019s disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases","volume":"2","author":"Bartram","year":"1993","journal-title":"Hum Mol Genet"},{"key":"2026020403045354200_bib16","first-page":"58","article-title":"Pharmacological and nutritional treatment trials in McArdle disease","volume":"26","author":"Quinlivan","year":"2007","journal-title":"Acta Myol"},{"key":"2026020403045354200_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.57.7.923","article-title":"Treatment of McArdle disease","volume":"57","author":"Haller","year":"2000","journal-title":"Arch Neurol"},{"key":"2026020403045354200_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1073\/pnas.45.6.791","article-title":"A functional disorder of muscle associated with the absence of phosphorylase","volume":"45","author":"Mommaerts","year":"1959","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020403045354200_bib19","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI103983","article-title":"Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle","volume":"38","author":"Schmid","year":"1959","journal-title":"J Clin Invest"},{"key":"2026020403045354200_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1152\/jappl.1993.75.2.745","article-title":"Respiratory gas exchange and metabolic responses during exercise in McArdle\u2019s disease","volume":"75","author":"Riley","year":"1993","journal-title":"J Appl Physiol (1985)"},{"key":"2026020403045354200_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/(SICI)1097-4598(199606)19:6<764::AID-MUS12>3.0.CO;2-L","article-title":"Impairment of muscle mitochondrial oxidative metabolism in McArdles\u2019s disease","volume":"19","author":"De Stefano","year":"1996","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib22","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1249\/MSS.0b013e3181aae96b","article-title":"Metabolic myopathies: functional evaluation by analysis of oxygen uptake kinetics","volume":"41","author":"Grassi","year":"2009","journal-title":"Med Sci Sports Exerc"},{"key":"2026020403045354200_bib23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1152\/jappl.1984.57.6.1749","article-title":"Metabolic control of cardiac output response to exercise in McArdle\u2019s disease","volume":"57","author":"Lewis","year":"1984","journal-title":"J Appl Physiol"},{"key":"2026020403045354200_bib24","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545689","volume-title":"Exercise testing and interpretation: a practical approach","author":"Cooper","year":"2001"},{"key":"2026020403045354200_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2362.2004.01423.x","article-title":"Oxygen consumption is increased relative to work rate in patients with McArdle\u2019s disease","volume":"34","author":"O\u2019Dochartaigh","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"2026020403045354200_bib26","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1164\/arrd.1984.129.2P2.S35","article-title":"The anaerobic threshold measurement to evaluate exercise performance","volume":"129","author":"Wasserman","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026020403045354200_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005792-198905000-00004","article-title":"Metabolic myopathies: evaluation by graded exercise testing","volume":"68","author":"Elliot","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"2026020403045354200_bib28","doi-asserted-by":"crossref","first-page":"254829","DOI":"10.1155\/2010\/254829","article-title":"Exercise stress testing in children with metabolic or neuromuscular disorders","volume":"2010","author":"Takken","year":"2010","journal-title":"Int J Pediatr"},{"key":"2026020403045354200_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","article-title":"New methods for calculating metabolic rate with special reference to protein metabolism","volume":"109","author":"Weir","year":"1949","journal-title":"J Physiol"},{"key":"2026020403045354200_bib30","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1172\/JCI555","article-title":"Sympathetic activation in exercise is not dependent on muscle acidosis: direct evidence from studies in metabolic myopathies","volume":"101","author":"Vissing","year":"1998","journal-title":"J Clin Invest"},{"key":"2026020403045354200_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","article-title":"A metabolic myopathy due to absence of muscle phosphorylase","volume":"30","author":"Pearson","year":"1961","journal-title":"Am J Med"},{"key":"2026020403045354200_bib32","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1152\/japplphysiol.01063.2013","article-title":"The \u201csecond wind\u201d in McArdle\u2019s disease patients during a second bout of constant work rate submaximal exercise","volume":"116","author":"Porcelli","year":"2014","journal-title":"J Appl Physiol (1985)"},{"key":"2026020403045354200_bib33","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch Neurol"},{"key":"2026020403045354200_bib34","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1152\/jappl.1992.72.5.1773","article-title":"Effect of deficient muscular glycogenolysis on extramuscular fuel production in exercise","volume":"72","author":"Vissing","year":"1992","journal-title":"J Appl Physiol (1985)"},{"key":"2026020403045354200_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.0954-6820.1967.tb12635.x","article-title":"The second wind phenomenon in McArdle\u2019s syndrome","volume":"472","author":"Pernow","year":"1967","journal-title":"Acta Med Scand Suppl"},{"key":"2026020403045354200_bib36","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1152\/jappl.1986.60.6.2020","article-title":"A new method for detecting anaerobic threshold by gas exchange","volume":"60","author":"Beaver","year":"1986","journal-title":"J Appl Physiol (1985)"},{"key":"2026020403045354200_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/jappl.1982.52.4.991","article-title":"Exercise hyperventilation in patients with McArdle\u2019s disease","volume":"52","author":"Hagberg","year":"1982","journal-title":"J Appl Physiol"},{"key":"2026020403045354200_bib38","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1152\/jappl.1983.55.5.1638","article-title":"Exercise hyperventilation in patients with McArdle\u2019s disease","volume":"55","author":"Whipp","year":"1983","journal-title":"J Appl Physiol"},{"key":"2026020403045354200_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mus.880060307","article-title":"Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm","volume":"6","author":"Brooke","year":"1983","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM198707093170203","article-title":"Myogenic hyperuricemia: a common pathophysiologic feature of glycogenosis types III, V, and VII","volume":"317","author":"Mineo","year":"1987","journal-title":"N Engl J Med"},{"key":"2026020403045354200_bib41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJM197304122881507","article-title":"Amino acid metabolism in McArdle\u2019s syndrome","volume":"288","author":"Wahren","year":"1973","journal-title":"N Engl J Med"},{"key":"2026020403045354200_bib42","first-page":"E167","article-title":"Relationship between ammonia, heart rate, and exertion in McArdle\u2019s disease","volume":"262","author":"Coakley","year":"1992","journal-title":"Am J Physiol"},{"key":"2026020403045354200_bib43","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0022-510X(95)00320-2","article-title":"A double blind, placebo controlled, crossover trial of D-ribose in McArdle\u2019s disease","volume":"136","author":"Steele","year":"1996","journal-title":"J Neurol Sci"},{"key":"2026020403045354200_bib44","first-page":"120","article-title":"A multi-parametric protocol to study exercise intolerance in McArdle\u2019s disease","volume":"34","author":"Ricci","year":"2015","journal-title":"Acta Myol"},{"key":"2026020403045354200_bib45","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.880070706","article-title":"A comparative study on glucagon effect between McArdle disease and Tarui disease","volume":"7","author":"Mineo","year":"1984","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.62.1.82","article-title":"No spontaneous second wind in muscle phosphofructokinase deficiency","volume":"62","author":"Haller","year":"2004","journal-title":"Neurology"},{"key":"2026020403045354200_bib47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1146\/annurev.bi.61.070192.005523","article-title":"Diseases of the mitochondrial DNA","volume":"61","author":"Wallace","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"2026020403045354200_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mus.10507","article-title":"Prevalence and progression of mitochondrial diseases: a study of 50 patients","volume":"28","author":"Arpa","year":"2003","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"2026020403045354200_bib50","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.58.8.1282","article-title":"Exercise-induced muscle \u201cburning,\u201d fatigue, and hyper-CKemia: mtDNA T10010C mutation in tRNA(Gly)","volume":"58","author":"Nishigaki","year":"2002","journal-title":"Neurology"},{"key":"2026020403045354200_bib51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s100380050145","article-title":"Adult onset limb-girdle type mitochondrial myopathy with a mitochondrial DNA np8291 A-to-G substitution","volume":"44","author":"Hirata","year":"1999","journal-title":"J Hum Genet"},{"key":"2026020403045354200_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1183\/09031936.93.01050445","article-title":"Exercise responses in patients with an enzyme deficiency in the mitochondrial respiratory chain","volume":"1","author":"Bogaard","year":"1988","journal-title":"Eur Respir J"},{"key":"2026020403045354200_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/brain\/awg028","article-title":"The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients","volume":"126","author":"Taivassalo","year":"2003","journal-title":"Brain"},{"key":"2026020403045354200_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ana.10594","article-title":"Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy","volume":"54","author":"Jeppesen","year":"2003","journal-title":"Ann Neurol"},{"key":"2026020403045354200_bib55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1042\/CS20140705","article-title":"Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression","volume":"128","author":"Gorman","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"2026020403045354200_bib56","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1042\/bst0311095","article-title":"The molecular machinery of Keilin\u2019s respiratory chain","volume":"31","author":"Rich","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"2026020403045354200_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0025-7753(00)71216-4","article-title":"The use of cardiopulmonary exercise test in patients with mitochondrial myopathies [in Spanish]","volume":"114","author":"Fern\u00e1ndez","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"2026020403045354200_bib58","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI115422","article-title":"Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect","volume":"88","author":"Haller","year":"1991","journal-title":"J Clin Invest"},{"key":"2026020403045354200_bib59","doi-asserted-by":"crossref","first-page":"R873","DOI":"10.1152\/ajpregu.00001.2011","article-title":"Exertional dyspnea in mitochondrial myopathy: clinical features and physiological mechanisms","volume":"301","author":"Heinicke","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026020403045354200_bib60","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/eurheartj\/ehs221","article-title":"EACPR\/AHA Joint Scientific Statement: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations","volume":"33","author":"Guazzi","year":"2012","journal-title":"Eur Heart J"},{"key":"2026020403045354200_bib61","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.96.7.2221","article-title":"Lung function and exercise gas exchange in chronic heart failure","volume":"96","author":"Wasserman","year":"1997","journal-title":"Circulation"},{"key":"2026020403045354200_bib62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/hc0102.101509","article-title":"Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension","volume":"105","author":"Sun","year":"2002","journal-title":"Circulation"},{"key":"2026020403045354200_bib63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1590\/S0100-879X2011000400013","article-title":"Relationship between work rate and oxygen uptake in mitochondrial myopathy during ramp-incremental exercise","volume":"44","author":"Gimenes","year":"2011","journal-title":"Braz J Med Biol Res"},{"key":"2026020403045354200_bib64","doi-asserted-by":"crossref","first-page":"254829","DOI":"10.1155\/2010\/254829","article-title":"Exercise stress testing in children with metabolic or neuromuscular disorders","volume":"2010","author":"Takken","year":"2010","journal-title":"Int J Pediatr"},{"key":"2026020403045354200_bib65","first-page":"457","article-title":"Exercise intolerance in patients with McArdle\u2019s disease or mitochondrial myopathies","volume":"1","author":"Chaussain","year":"1992","journal-title":"Eur J Med"},{"key":"2026020403045354200_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/eurjhf\/hfp186","article-title":"Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease","volume":"12","author":"Limongelli","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026020403045354200_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.2007.122648","article-title":"Causes of death in pedigrees with the 3243A&gt;G mutation in mitochondrial DNA","volume":"79","author":"Majamaa-Voltti","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026020403045354200_bib68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.0b013e31827b1a2f","article-title":"High risk of severe cardiac adverse events in patients with mitochondrial m.3243A&gt;G mutation","volume":"80","author":"Malfatti","year":"2013","journal-title":"Neurology"},{"key":"2026020403045354200_bib69","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehv306","article-title":"Sudden adult death syndrome in m.3243A&gt;G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults","volume":"37","author":"Ng","year":"2016","journal-title":"Eur Heart J"},{"key":"2026020403045354200_bib70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.167.2.211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing","volume":"167","author":"American Thoracic Society","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403045354200_bib71","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1249\/01.mss.0000177341.89478.06","article-title":"Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options","volume":"37","author":"Tarnopolsky","year":"2005","journal-title":"Med Sci Sports Exerc"},{"key":"2026020403045354200_bib72","doi-asserted-by":"crossref","first-page":"H2122","DOI":"10.1152\/ajpheart.00479.2010","article-title":"Impaired cardiac reserve and severely diminished skeletal muscle O2 utilization mediate exercise intolerance in Barth syndrome","volume":"301","author":"Spencer","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020403045354200_bib73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1152\/japplphysiol.00343.2009","article-title":"The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise","volume":"107","author":"Robinson","year":"2009","journal-title":"J Appl Physiol (1985)"},{"key":"2026020403045354200_bib74","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bbrc.2005.10.108","article-title":"Simvastatin induces impairment in skeletal muscle while heart is protected","volume":"338","author":"Sirvent","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020403045354200_bib75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026020403045354200_bib76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3810\/psm.2012.11.1991","article-title":"Impact of coenzyme Q-10 on parameters of cardiorespiratory fitness and muscle performance in older athletes taking statins","volume":"40","author":"Deichmann","year":"2012","journal-title":"Phys Sportsmed"},{"key":"2026020403045354200_bib77","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1164\/ajrccm.164.3.2005110","article-title":"Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy","volume":"164","author":"Flaherty","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403045354200_bib78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mus.880080704","article-title":"Type 2 fiber predominance in muscle cramp and exertional myalgia","volume":"8","author":"Telerman-Toppet","year":"1985","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mus.24984","article-title":"Reverse fiber type disproportion: a distinct metabolic myopathy","volume":"54","author":"Cooper","year":"2016","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib80","article-title":"Exercise responses in patients with chronically high creatine kinase levels","author":"Cooper","journal-title":"Muscle Nerve"},{"key":"2026020403045354200_bib81","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1161\/01.CIR.84.4.1868","article-title":"Reduced aerobic enzyme activity in skeletal muscles of patients with heart failure","volume":"84","author":"Wasserman","year":"1991","journal-title":"Circulation"},{"key":"2026020403045354200_bib82","first-page":"1","article-title":"Response to submaximal and maximal exercise after bedrest and training","volume":"38","author":"Saltin","year":"1968","journal-title":"Circulation"},{"key":"2026020403045354200_bib83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.ph.38.030176.001421","article-title":"Biochemical adaptations to endurance exercise in muscle","volume":"38","author":"Holloszy","year":"1976","journal-title":"Annu Rev Physiol"},{"key":"2026020403045354200_bib84","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/bmj.301.6758.953","article-title":"Aerobic work capacity in patients with chronic fatigue syndrome","volume":"301","author":"Riley","year":"1990","journal-title":"BMJ"},{"key":"2026020403045354200_bib85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"key":"2026020403045354200_bib86","first-page":"351","article-title":"State of the art in muscle lipid diseases","volume":"29","author":"Liang","year":"2010","journal-title":"Acta Myol"},{"key":"2026020403045354200_bib87","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1212\/WNL.59.7.1046","article-title":"Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose","volume":"59","author":"\u00d8rngreen","year":"2002","journal-title":"Neurology"},{"key":"2026020403045354200_bib88","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ana.410360606","article-title":"An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry","volume":"36","author":"Bank","year":"1994","journal-title":"Ann Neurol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/Supplement_1\/S129\/66716336\/annalsats_14_supplement_1_s129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/Supplement_1\/S129\/66716336\/annalsats_14_supplement_1_s129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:05:13Z","timestamp":1770192313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/14\/Supplement_1\/S129\/8454213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":88,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2017,7,1]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201701-014fr","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2017,7,1]]}}}